Reddit Posts
💰💰💰Good morning! #premarket #watchlist 01/24 $AXLA -Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue (+63%), $PYPD -Provides Positive Regulatory Update for D-PLEX for the Prevention of Surg(+62%), $GROM -no news+big volume(+51%)
Mentions
And PYPD is a company that just had the ending of their trial for what is essentially a Band-Aid for post-surgical. It's thousands of layers of dermal tape that slowly dissolve, and at each layer, there are antibiotics. This is allowing localized antibiotics so that way the body doesn't need to take as much of a dose. In its trial, it was reducing high risk infections by 60%, and reduce chances of death by almost 30%.
Over the next few months, I'm expecting some solid moves: Riley (90% conviction for 100% gain) should pop by mid-August, $Anro (80% conviction for 140% gain) in the next couple weeks, $ATHE (75% for 50% gain) sometime in two months, $CING (70% for 200% gain) in three, and $SLS (90% for 600% gain) in four, $PYPD (95% for 100% gain) eoy. When each one jumps, I'll cash out some profits-keeping 20% to stash in my long-term port. The rest of the gains get split between whatever plays are still active.... ignoring my 5% rule, as I'm considering this as one play. As each stock hits, the leftover money keeps cycling forward, giving me more firepower for the next move... I think each move, will be enough of a move, I only need to be right on a few of these. 50:50 shares/call splits on ANRO and SLS RILY 30/70 shares/calls. Everything else is shares only.
Also holding PYPD it might do as IMNN.
So far today. I have not really done many plays. Bought some PYPD - sold for a loss cause am dumb. Now I am sitting on 1 share of OMH, SOGP, KNW, NRXP and 50 shares of KLTO and basically just letting all of them ride till market open then putting a 20% TSL on them all. Might make actual plays later but these are just fun for now Other than that. Hope you all get out with a green day today and I post again in about 1.5 hours stating the IPOs - if there are any Have a fun day all
PYPD update NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced positive topline results from its pivotal SHIELD II Phase 3 trial of D-PLEX100 for the prevention of SSIs in patients undergoing abdominal colorectal surgery with large incisions, which has received Fast Track designation from the FDA. "The positive results of our Phase 3 pivotal trial provide clear and compelling evidence of D-PLEX100's ability to significantly reduce SSIs, a major burden on patients and healthcare systems, while improving clinical outcomes for both patients and physicians," said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid.
SL dinged in PYPD, but green at least. Two profitable trades in PM, unusual but I like it
PYPD Float 4.61 M News: GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report topline data for the SHIELD II Phase 3 trial, evaluating D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery, on Monday, June 9, at 8:30 a.m. ET. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. Conference Call Dial-In & Webcast Information: Date: Monday, June 9, 2025 Time: 8:30 AM Eastern Time Conference Call: https://register-conf.media-server.com/register/BIb5bb85aa1ffc4940b78f7191b278ca77 Webcast: https://edge.media-server.com/mmc/p/k6n5hrft About PolyPid PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. This stock could do as PRFR.
I looked into my crystal ball and it said it would be either PRPH, PYPD or WLLW. No refunds
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: PYPD. Message /u/zjz if they're above 500 million-ish market cap and not related to pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: PYPD. Message /u/zjz if they're above 500 million-ish market cap and not related to pennies/OTC.
Adding more PYPD PHASE 3 ABIUT TO END, and a littel bird whispered me that it's going to explode soon
I totally found it!!! The next thing #PYPD https://finance.yahoo.com/news/wall-street-analysts-believe-polypid-135501656.html
PYPD ??? Anyone no something about this?